Ancilia Biosciences

About Ancilia Biosciences

Ancilia Bio is a company focused on harnessing the natural power of CRISPR to create beneficial bacterial products with immunity against destructive viruses. Their mission is to leverage CRISPR and proprietary platforms to tackle the virome and develop novel therapies and products using beneficial bacteria as live biotherapeutics for various applications.

Products & Services

CoVE™ (Computational Virome Engine):A platform that addresses challenges in virome identification and characterization, with the ability to computationally identify and design solutions to counter destructive viruses.

EPIC™ (Enhancing Phage Immunity with CRISPR):A platform that uses CRISPR to develop new classes of live biotherapeutics and bacterial products with immunity against viruses, enhancing efficacy across various applications.

Live Biotherapeutics and Bacterial Products:Products targeting therapeutics, agriculture, and industrial biotechnology, designed to utilize beneficial bacteria with CRISPR-mediated immunity.

Specialties

CRISPR Technology Virome Identification and Targeting Live Biotherapeutics Bacterial Product Development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 3000000 MR: - FA: 3 million FAN: 3000000	D: 2024-10-23 FD: 2024-10-23	2 investors
2	RT: Equity Financing T: - FT: Equity Financing	A: 4200000 MR: - FA: $4.2 million FAN: 4200000	D: 2024-07-17 FD: 2024-07-17	6 investors

Grant Latest

2024-10-23

$3.0M

2 investors (Pro only)

Equity Financing 2024-07-17

$4.2M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Alexandra Sakatos

Co-founder, CEO

LinkedIn (Pro only)

R

Rodolphe Barrangou

Co-founder, CSO (Part time)

LinkedIn (Pro only)

D

David Paez-Espino

Co-founder, CTO

M

Matthew Foley

Academic Collaborations

D

Daena Schuh

Associate Scientist

F

Fotis Baltoumas

Bioinformatics Specialist

View 21 more team members with Pro

Unlock Full Team Directory

Recent News